(Q46246409)

English

Azathioprine is superior to budesonide in achieving and maintaining mucosal healing and histologic remission in steroid-dependent Crohn's disease

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19009634

Azathioprine is superior to budesonide in achieving and maintaining mucosal healing and histologic remission in steroid-dependent Crohn's disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19009634

Crohn's disease

1 reference

based on heuristic

inferred from title

0 references

author name string

Gerassimos J Mantzaris

1

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19009634

Angeliki Christidou

2

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19009634

Michael Sfakianakis

3

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19009634

Anastassios Roussos

4

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19009634

Stavroula Koilakou

5

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19009634

Kalliopi Petraki

6

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19009634

Paraskevi Polyzou

7

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19009634

publication date

1 March 2009

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19009634

Inflammatory Bowel Diseases

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19009634

15

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19009634

3

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19009634

375-382

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19009634

Impact of inflammatory bowel disease on health-related quality of life

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20777

21 January 2018

Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20777

21 January 2018

The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20777

21 January 2018

A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20777

21 January 2018

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20777

21 January 2018

Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20777

21 January 2018

Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20777

21 January 2018

Switch from systemic steroids to budesonide in steroid dependent patients with inactive Crohn's disease

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20777

21 January 2018

Replacement of conventional glucocorticoids by oral pH-modified release budesonide in active and inactive Crohn's disease: results of an open, prospective, multicenter trial

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20777

21 January 2018

Budesonide prolongs time to relapse in ileal and ileocaecal Crohn's disease. A placebo controlled one year study

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20777

21 January 2018

Budesonide versus mesalamine for maintaining remission in patients refusing other immunomodulators for steroid-dependent Crohn's disease

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20777

21 January 2018

Maintenance of Crohn's disease over 12 months: fixed versus flexible dosing regimen using budesonide controlled ileal release capsules

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20777

21 January 2018

Healing of severe recurrent ileitis with azathioprine therapy in patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20777

21 January 2018

Endoscopic and histologic healing of Crohn's (ileo-) colitis with azathioprine

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20777

21 January 2018

Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires du Tube Digestif (GETAID)

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20777

21 January 2018

Review article: the burden of hepatic encephalopathy

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20777

21 January 2018

Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20777

21 January 2018

Identifiers

10.1002/IBD.20777

1 reference

https://api.fatcat.wiki/v0/release/5igk3cavwvgqtd6nplyvakcdsa

30 July 2022

based on heuristic

mapped directly with Wikidata item

release_5igk3cavwvgqtd6nplyvakcdsa

1 reference

https://api.fatcat.wiki/v0/release/5igk3cavwvgqtd6nplyvakcdsa

30 July 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

https://api.fatcat.wiki/v0/release/5igk3cavwvgqtd6nplyvakcdsa

30 July 2022

based on heuristic

mapped directly with Wikidata item

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46246409&oldid=2102112545"